Search the Newsreel

Cyclerion Therapeutics Inc (CYCN) Institutional Confidence

This article provides an overview of Cyclerion Therapeutics Inc (CYCN) and its institutional confidence score. It includes the stock's current trading price, market capitalization, and a table detailing institutional shareholdings and changes in shares held by various entities and individuals. The institutional confidence score …

UNCY|Unicycive Therapeutics Inc|Price:5.410|Chg%:-0.050

Unicycive Therapeutics Inc (UNCY) is a biotechnology company focused on developing treatments for kidney diseases, with its lead drug candidate, oxylanthanum carbonate (OLC), targeting hyperphosphatemia in dialysis patients, and UNI-494 for acute kidney injury. The article provides current stock information, company details including key …

PureCycle Technologies, Inc. Revenue Breakdown – NASDAQ:PCT

This article provides an overview of the revenue breakdown for PureCycle Technologies, Inc. (NASDAQ: PCT) on TradingView. It highlights that detailed financial segments and regional performance data are available, indicating various categories such as source and country.

(PCT) Movement Within Algorithmic Entry Frameworks

This article analyzes Purecycle Technologies Inc. (NYSE: PCT) using AI models, suggesting a near-term neutral sentiment before mid and long-term weakness. It outlines distinct institutional trading strategies, including long, breakout, and short positions, along with multi-timeframe signal analysis, and highlights an exceptional risk-reward short …

PureCycle Technologies (PCT) On Its Japan Packaging Deal Is The Stock A Bargain Or Priced In

PureCycle Technologies (PCT) announced a partnership to supply high-purity recycled BOPP film in Japan, yet its stock price has declined significantly. While a popular narrative suggests the stock is undervalued at $11.67 based on future growth and profitability, another view highlights its high price-to-book …

PCYO|Pure Cycle Corp|Price:10.760|Chg%:+0.080

This article provides a comprehensive stock analysis of Pure Cycle Corp (PCYO) by TradingKey, highlighting its healthy fundamentals, high growth potential, and fair valuation within the Water & Related Utilities industry. The company's revenue has grown consistently, and its latest annual income is significant. …

Chemical recycling innovations and regulations see both applause and scrutiny

Chemical recycling is a divisive topic, with organizations like the EPA supporting its use for economic and environmental benefits, while groups such as the NRDC raise concerns about hazardous chemical reporting and potential community exposure. Recent developments include an EPA visit to Eastman's facility …

PureCycle Technologies (PCT) CFO amends Form 3 to correct 136,895-share holding

PureCycle Technologies' CFO, Donald Carpenter, filed an amended Form 3 to correct a clerical error in his previously reported share ownership. The amendment clarifies that he holds 136,895 shares of Common Stock as of March 1, 2026, with no new transactions involved. This correction …

PureCycle Technologies, Inc. (PCTTW) Analyst insights, Price targets and Recommendations

The article provides a snapshot of PureCycle Technologies, Inc. (PCTTW)'s analyst insights, price targets, and recommendations. It shows the stock trading at 1.6600 USD, down 7.78% at market close on July 24th. The content also includes general market data and popular trending tickers.

Purecycle Technologies Inc (PCT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Purecycle Technologies Inc (PCT), highlighting its current earnings forecast score of 7.00 and an average analyst price target of $15.00. Analysts largely recommend a "Buy" for PCT stock, with expected revenue for the next quarter at $5.80M …

PureCycle Technologies (PCT) Targets Japan Packaging, Is The Stock Still Cheap?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Why This New Packaging Partnership Matters for PureCycle Technologies Stock PureCycle Technologies (PCT) drew fresh investor attention after announcing a partnership with RM …

Debt to assets ratio of PureCycle Technologies Inc – LS:A2QPLB

The article discusses the debt to assets ratio for PureCycle Technologies Inc (LS:A2QPLB), presenting financial data available through TradingView. It provides an overview of the company's financials for research purposes. The content primarily focuses on data availability and platform features rather than an in-depth …

Motorcycle Holdings Limited (ASX:MTO)

PureCycle will take questions on corporate developments Aug. 6

PureCycle Technologies (Nasdaq: PCT) will host a second quarter 2026 corporate update conference call on Thursday, August 6, 2026, at 5:00 p.m. EDT to discuss recent corporate developments. A press release will be issued prior to the call, which will include a live Q&A …

Form 4 Purecycle Technologies Holdings Corp For: 23 July By Investing.com

This article announces the filing of a Form 4 for Purecycle Technologies Holdings Corp, pertaining to activities on July 23rd. The brief announcement provides no further details but lists the stock symbol PCT and its current performance.

PureCycle Technologies (PCT) CFO amends insider stake to 132,522 shares

PureCycle Technologies' Chief Financial Officer, Donald Carpenter, has filed an amended Form 4/A to correct a prior clerical error regarding his insider shareholdings. The updated filing shows that he directly holds 132,522 shares of Common Stock as of May 20, 2026. This amendment clarifies …

PureCycle Technologies (PCT) corrects CFO Carpenter’s reported share holdings

PureCycle Technologies (PCT) has filed an amended insider ownership report (Form 3/A) for its Chief Financial Officer, Donald Carpenter. The amendment corrects a previous clerical error, clarifying that Carpenter directly holds 136,895 shares of Common Stock as of March 1, 2026. This filing updates …

PureCycle Schedules Second Quarter 2026 Corporate Update

PureCycle Technologies, Inc. announced it will host a conference call on Thursday, August 6, 2026, to provide a corporate update on recent developments and activities from the second quarter of 2026. A press release detailing these developments will precede the call. The company specializes …

PureCycle กำหนดการรายงานข้อมูลอัปเดตของบริษัทประจำไตรมาสที่ 2 ปี 2026

PureCycle Technologies, Inc. (NASDAQ: PCT) will host its second-quarter 2026 corporate update conference call on Thursday, August 8, 2026, at 11:00 AM Eastern Time. The update will provide details on the company's progress and financial results. Investors and interested parties can access the webcast …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Unicycive Therapeutics, Inc. (UNCY) following a significant drop in its stock price. This investigation comes after the FDA issued a second Complete Response Letter regarding the company's kidney disease therapy, oxylanthanum, citing unresolved third-party …

Cycliq Returns to Positive Operating Cash Flow in Q4 FY2026 as End of Financial Year Campaign Drives Sales Momentum

Cycliq Group Lifts Operating Cash Position to $536,000 in June Quarter as Revenue Grows

PCT stock trades on Nasdaq as PureCycle reports widening losses and advances recycling capacity

PureCycle Technologies Inc. (PCT) is trading on Nasdaq, with its stock reflecting the company's efforts to commercialize polypropylene recycling. While PureCycle has seen revenue growth from a near-zero base, it continues to report widening net losses as it invests heavily in building its first …

Form 13D/A CYCLERION THERAPEUTICS For: 21 July By Investing.com

This article announces the filing of a Form 13D/A for Cyclerion Therapeutics (CYCN) on July 21. It is a brief, technical update from Investing.com, typical of financial news reporting on SEC filings. The article itself contains no additional commentary or details beyond the filing …

Cyclerion Therapeutics (CYCN) investor reports 19.4% stake and preferred share conversion

Peter M. Hecht has updated his beneficial ownership in Cyclerion Therapeutics, Inc. (CYCN), now holding 910,240 shares of Common Stock, representing 19.4% of the outstanding class. This change resulted from the forfeiture of options for 110,984 shares and the conversion of 351,037 non-voting Series …

Cyclerion Therapeutics (CYCN) director converts 351,037 preferred to common shares

Cyclerion Therapeutics director Peter M. Hecht converted 351,037 shares of Series A Convertible Preferred Stock into an equal number of Common Stock shares on July 16, 2026, eliminating all his preferred holdings. This transaction increased his direct common stock ownership to 910,240 shares, and …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating Unicycive Therapeutics, Inc. (UNCY) after the FDA issued a second Complete Response Letter for its kidney disease therapy, oxylanthanum, citing unresolved manufacturing deficiencies. The law firm is encouraging investors who purchased Unicycive securities to join their investigation …

PCT5917096 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the PureCycle Technologies, Inc. 7.25% 15-AUG-2030 bond (PCT5917096 FINRA). It details the current coupon rate of 7.25% and indicates that the next interest payment is scheduled for August 17, 2026. The bond's market status is closed, with …

Cyclerion Therapeutics (Nasdaq:CYCN) - Stock Analysis

This Simply Wall St analysis provides an overview of Cyclerion Therapeutics (CYCN), highlighting its biopharmaceutical focus on sGC stimulators for CNS and peripheral diseases. The report details the company's financial health, significant risks including declining earnings forecasts and cash runway issues, and recent corporate …

PCT5917096 Bond Profile — Key Metrics

This article provides key metrics for the PCT5917096 bond issued by PureCycle Technologies, Inc. The convertible bond has a 7.25% coupon rate, an issue date of September 24, 2024, and a maturity date of August 15, 2030. PureCycle Technologies, Inc. specializes in recycling waste …

PureCycle settles lawsuit claiming misleading statements for $12M

PureCycle has agreed to settle a lawsuit alleging it made misleading statements for $12 million. The settlement resolves claims that the company disseminated false information. This news was reported by Jim Johnson on May 16, 2024.

Mitsui (TSE:8031) Could Be 28% Undervalued On Its Cleaner Energy Narrative

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Mitsui (TSE:8031) is back in focus after PureCycle Technologies, RM TOHCELLO and Mitsui reported progress on their recycled polypropylene partnership in Japan, moving …

Frontier tech research, news & data

This article provides an update on an insider transaction for BICYCLE THERAPEUTICS PLC (BCYC). A Form 3/4/5 filing was made on July 17, 2026, which can be viewed on SEC.gov. The article also mentions a "Power Delivery Gap Report" available from MLQ.ai, analyzing the …

Pure Cycle Q3 revenue rises 60% to $8.222M, net income $2.9M

Pure Cycle Corporation reported a 60% increase in Q3 revenue to $8.222 million and a 31% rise in net income to $2.9 million, driven by accelerated land development at Sky Ranch and higher water revenue from oil and gas demand. The company is ahead …

Bicycle Therapeutics (BCYC) grants 60,000 stock options to CSO

Bicycle Therapeutics plc's Chief Scientific Officer, Michael Skynner, was granted 60,000 employee stock options on July 15, 2026. These options allow for the purchase of Ordinary Shares at an exercise price of $4.21 per share and will vest over time, with one-fourth vesting on …

Bicycle Therapeutics (BCYC) awards 60,000 options to supply chain chief

Bicycle Therapeutics (BCYC) has granted its Chief Product and Supply Chain Officer, Michael Charles Ferguson Hannay, 60,000 employee stock options. The options have an exercise price of $4.21 per share and expire on July 15, 2036. The vesting schedule begins with one-fourth of the …